Trimetazidine counteracts tacrolimus nephrotoxicity in a hypertensive liver transplant patient.
Zoppo
A
A
Faggiotto
A
A
Redaelli
L
L
Campi
S
S
Catapano
A L
AL
D006801:Humans; D006973:Hypertension / Q000150:complications*; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000037:antagonists & inhibitors; D007674:Kidney Diseases / Q000139:chemically induced* / Q000188:drug therapy; D008103:Liver Cirrhosis / Q000150:complications / Q000601:surgery*; D016031:Liver Transplantation; D016559:Tacrolimus / Q000009:adverse effects* / Q000037:antagonists & inhibitors; D014292:Trimetazidine / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D007166:Immunosuppressive Agents; D014665:Vasodilator Agents; D014292:Trimetazidine; D016559:Tacrolimus